Atea Pharmaceuticals, Inc. (AVIR)

4.67 +0.05 (+1.08%) USD  |  NASDAQ  |  Feb 26, 16:00
4.67 0.00 (0.00%) After-Hours: 17:55
More

Atea Pharmaceuticals Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for AVIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Oramed Pharmaceuticals, Inc. Upgrade
Aclaris Therapeutics, Inc. Upgrade
PMV Pharmaceuticals, Inc. --
Instil Bio, Inc. --
Coya Therapeutics, Inc. Upgrade